Invacare Co. (IVC) to Distribute Quarterly Dividend of $0.01 on April 17th

Share on StockTwits

Invacare Co. (NYSE:IVC) declared a quarterly dividend on Thursday, February 20th, RTT News reports. Investors of record on Friday, April 3rd will be paid a dividend of 0.0125 per share by the health services provider on Friday, April 17th. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.55%.

Invacare has raised its dividend payment by an average of 10.1% per year over the last three years. Invacare has a dividend payout ratio of -18.5% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Invacare to earn $0.02 per share next year, which means the company may not be able to cover its $0.05 annual dividend with an expected future payout ratio of 250.0%.

Shares of IVC stock opened at $9.01 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.08 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average price of $8.56 and a 200 day moving average price of $7.79. Invacare has a 12 month low of $4.13 and a 12 month high of $11.63.

Invacare (NYSE:IVC) last issued its earnings results on Monday, February 10th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.15). The firm had revenue of $232.90 million for the quarter, compared to analyst estimates of $241.26 million. Invacare had a negative return on equity of 10.85% and a negative net margin of 5.75%. The business’s revenue for the quarter was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.16) EPS. On average, sell-side analysts expect that Invacare will post -0.14 earnings per share for the current year.

Several research firms have issued reports on IVC. ValuEngine upgraded shares of Invacare from a “sell” rating to a “hold” rating in a research note on Saturday, February 15th. Needham & Company LLC restated a “buy” rating and issued a $17.00 price objective on shares of Invacare in a research note on Monday, February 10th. Finally, Zacks Investment Research downgraded shares of Invacare from a “hold” rating to a “sell” rating in a research note on Thursday, February 13th.

Invacare Company Profile

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Read More: What does the Producer Price Index (PPI) tell investors?

Dividend History for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.